# Risperidone or Cognitive-Behavioral Therapy for Improving Medication Treatment for Obsessive-compulsive Disorder

> **NCT00389493** · NA · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 100 (actual)

## Conditions studied

- Obsessive-Compulsive Disorder

## Interventions

- **DRUG:** Risperidone
- **BEHAVIORAL:** Exposure/ritual prevention therapy (EX/RP)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00389493
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2012-06
- **Final completion:** 2012-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2014-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00389493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00389493, "Risperidone or Cognitive-Behavioral Therapy for Improving Medication Treatment for Obsessive-compulsive Disorder". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00389493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*